Research Associate
No Content
Scientific Research
Working-Papers
No Content
Paper Publications
More>-
Electric-Field-Driven Ferredoxin 1-Independent Cuproptosis Induction Overcomes Therapy-Induced Resistance in Glioblastoma. ACS nano, 2026.
-
Levetiracetam reverses temozolomide resistance in glioblastoma by blocking drug efflux through RAB5A/CD63-RAB35 axis. Cancer Letters, 2026.
-
Wireless Electro‐Fenton Overcomes Tumor Electric Field Treatment Resistance. Advanced Materials, 2026.
-
Biomimetic hybrid vesicle nanoplatform with Pt-BaTiO3 for sonodynamic-immunotherapy of glioblastoma. Chemical Engineering Journal, 2026.
-
A tumor microenvironment model for glioma diagnosis and therapeutic evaluation based on the analysis of tissues and biological fluids. iScience, 2026.
-
Shichuan Tan, Huizhong Chi, Pin Wang, Rongrong Zhao, Qinran Zhang, Zijie Gao, Hao Xue, Qilin Tang and Gang Li. Protein tyrosine phosphatase receptor type O serves as a key regulator of insulin resistance-induced α-synuclein aggregation in Parkinson’s disease. Cellular and Molecular Life Sciences, 2026.
-
Qinran Zhang, Yuhong Xu, Shiyang Kang, Junquan Chen, Zhihao Yao, Haitao Wang, Qinian Wu, Qi Zhao, Qihua Zhang, Rui‐hua Xu, Xiufen Zou and Huiyan Luo. A novel computational framework for integrating multidimensional data to enhance accuracy in predicting the prognosis of colorectal cancer. MedComm–Future Medicine, 2026.
-
Qinran Zhang, Suoqin Jin and Xiufen Zou. scAB detects multiresolution cell states with clinical significance by integrating single-cell genomics and bulk sequencing data. Nucleic acids research, 2026.
Patents
No Content
Published Books
No Content
Research Projects
More>Research Team
No Content